C.R. Sincock II
Managing Partner
C.R. Sincock, II, graduated magna cum laude as a member of Phi Beta Kappa from Harvard College in 2007 with an A.B. in economics. He was chairman of the Harvard Political Union, John Harvard Scholar and a winner of the Exposé Writing Award.
After graduation, Sincock joined the energy desk at QVT Financial LP, a multi-strategy hedge fund based in New York City. He pursued advanced coursework in abstract and applied mathematics at Columbia University and Harvard University before entering Harvard Business School, graduating in 2013 as a Baker Scholar with an M.B.A. in general management.
Sincock subsequently joined Avfuel Corporation, a global supplier of aviation fuel and services with sales in excess of $2 billion in revenue, where he is now executive vice president and a member of the board of directors. He was later named president and CEO of Avfuel’s sister company, Avflight, which owns and operates FBOs and other infrastructure at 31 airports around the world.
In 2014, Sincock founded Transhuman Capital, a venture firm focused on investments in hard science that solve the biggest problems of humanity. Later that same year, he completed the firm’s first investment in the seed round of Roivant Sciences and added to the position in several follow-on rounds. In 2019, he led the seed round for Kriya Therapeutics and subsequently made significant investments in follow-on rounds. He served on the Board of Directors at Kriya Therapeutics for three years and now holds the position of Founding Investor and Senior Strategic Advisor.